Bevacizumab: Anti-VEGF monoclonal antibody, avastin, rhumab-VEGF

被引：0
|
作者：
不详
机构：
来源：
Drugs in R & D | 2002年 / 3卷 / 1期
关键词：
Bevacizumab; Irinotecan; Metastatic Breast Cancer; Folinic Acid; Retinal Vein Occlusion;
D O I：
10.2165/00126839-200203010-00006
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：28 / 30
页数：2
相关论文
共 50 条
  • [1] Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
    Ferrara, N
    Hillan, KJ
    Novotny, W
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 333 (02) : 328 - 335
  • [2] Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab
    Chen, HX
    Gore-Langton, RE
    Cheson, BD
    ONCOLOGY-NEW YORK, 2001, 15 (08): : 1017 - +
  • [3] Anti-VEGF bevacizumab (Avastin®) for radiation optic neuropathy
    Finger, Paul T.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (02) : 335 - 338
  • [4] Scintigraphic imaging of VEGF-A expression with radiolabeled ANTI-VEGF monoclonal antibody (bevacizumab)
    Scheer, M.
    Stollman, T. H.
    Leenders, W. P. J.
    Verrijp, K.
    Soede, A. C.
    Oyen, W. J. G.
    Ruers, T. J. M.
    Boatman, O. C.
    ANNALS OF ONCOLOGY, 2008, 19 : I38 - I38
  • [5] Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome
    Sekiguchi, Yukari
    Misawa, Sonoko
    Shibuya, Kazumoto
    Nasu, Saiko
    Mitsuma, Satsuki
    Iwai, Yuta
    Beppu, Minako
    Sawai, Setsu
    Ito, Shoichi
    Hirano, Shigeki
    Nakaseko, Chiaki
    Kuwabara, Satoshi
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (12): : 1346 - 1348
  • [6] Mechanisms of action of the anti-VEGF monoclonal antibody bevacizumab on chronic lymphocytic leukemia cells
    Bogusz, Jakub
    Majchrzak, Agata
    Medra, Aleksandra
    Cebula-Obrzut, Barbara
    Robak, Tadeusz
    Smolewski, Piotr
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2013, 67 : 107 - 118
  • [7] Specific imaging of VEGF-A expression with radiolabeled anti-VEGF monoclonal antibody
    Stollman, Thamar H.
    Scheer, Marian G. W.
    Leenders, William P. J.
    Verrijp, Kiek C. N.
    Soede, Annemieke C.
    Oyen, Wim J. G.
    Ruers, Theo J. M.
    Boerman, Otto C.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (10) : 2310 - 2314
  • [8] Anti-VEGF antibody bevacizumab (Avastin) with 5FU/LV as third line treatment for colorectal cancer
    Emmanouilides C.
    Pegram M.
    Robinson R.
    Hecht R.
    Kabbinavar F.
    Isacoff W.
    Techniques in Coloproctology, 2004, 8 (Suppl 1) : S50 - S52
  • [9] Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
    Napoleone Ferrara
    Kenneth J. Hillan
    Hans-Peter Gerber
    William Novotny
    Nature Reviews Drug Discovery, 2004, 3 : 391 - 400
  • [10] TREATMENT OF CNS RADIATION NECROSIS WITH BEVACIZUMAB, AN ANTI-VEGF ANTIBODY
    Levin, Victor A.
    Jackson, Edward
    McAlle, Krista
    Prabhu, Sujit
    Gilbert, Mark
    Kumar, Ashok J.
    NEURO-ONCOLOGY, 2009, 11 (02) : 223 - 223
12345